Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,735 | 10,169 | 7,910 | 5,190 | 2,789 |
| Depreciation Amortization | 794 | 3,266 | 2,451 | 1,639 | 820 |
| Income taxes - deferred | -177 | -600 | -613 | -428 | -251 |
| Accounts receivable | -958 | 675 | -140 | -275 | -1,227 |
| Accounts payable and accrued liabilities | 184 | 50 | 232 | 429 | 309 |
| Other Working Capital | -640 | 476 | 685 | 90 | 49 |
| Other Operating Activity | 781 | -473 | -26 | -108 | 945 |
| Operating Cash Flow | $2,719 | $13,563 | $10,499 | $6,537 | $3,434 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52 | -254 | -195 | -133 | -61 |
| Sale Of Investment | N/A | 47 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -1 | -1 | -1 | -1 |
| Other Investing Activity | 0 | -1 | -2 | -1 | -1 |
| Investing Cash Flow | $-52 | $-208 | $-197 | $-134 | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -969 | -9,093 | -7,174 | -5,221 | -2,464 |
| Common Stock Issued | 340 | 1,803 | 1,185 | 978 | 585 |
| Common Stock Repurchased | N/A | -504 | 0 | N/A | 0 |
| Dividend Paid | N/A | -3,555 | -1,762 | -878 | N/A |
| Other Financing Activity | 85 | 178 | 99 | 100 | 55 |
| Financing Cash Flow | $-544 | $-11,171 | $-7,652 | $-5,021 | $-1,824 |
| Exchange Rate Effect | -124 | 153 | 103 | -3 | 76 |
| Beginning Cash Position | 8,871 | 6,534 | 6,534 | 6,534 | 6,534 |
| End Cash Position | 10,870 | 8,871 | 9,288 | 7,913 | 8,159 |
| Net Cash Flow | $1,999 | $2,337 | $2,754 | $1,378 | $1,624 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,719 | 13,563 | 10,499 | 6,537 | 3,434 |
| Capital Expenditure | -52 | -254 | -195 | -133 | -61 |
| Free Cash Flow | 2,667 | 13,309 | 10,304 | 6,404 | 3,373 |